Off-label prescribing in a French hospital

Pharmacy World and Science

Volumn 29, Issue 2, 2007, Pages 97-100

  Cras, Audrey ^a   Conscience, Marie Agnès ^a   Rajzbaum, Gérald ^a   Lillo Le Louët, Agnès ^b   Lopez, Nathalie ^a   Tersen, Isabelle ^a   Bezie, Yvonnick ^a  

^a SAINT JOSEPH HOSPITAL   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Adverse drug reactions; France; Hospital; Off label prescribing; Prescribing

Indexed keywords

ANTIASTHMATIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIULCER AGENT; CORTICOSTEROID; PROTON PUMP INHIBITOR; VITAMIN;

AGED; ARTICLE; CONTROLLED STUDY; DRUG APPROVAL; DRUG DOSAGE FORM; DRUG DOSE REGIMEN; DRUG MARKETING; FEMALE; FRANCE; GENERAL HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; OFF LABEL DRUG USE; PRESCRIPTION; PRESCRIPTIVE AUTHORITY; PROSPECTIVE STUDY; TREATMENT INDICATION;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ANTI-ULCER AGENTS; DRUG LABELING; DRUG UTILIZATION REVIEW; FEMALE; FIBRINOLYTIC AGENTS; FRANCE; HOSPITALS, GENERAL; HUMANS; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; PROFESSIONAL ROLE;

EID: 33847308638     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-006-9064-0     Document Type: Article

References (11)

1. Cuzzolin L, Zaccaron A, Fanos V. Unlicensed and off-label uses of drugs in paediatrics: a review of the literature. Fundam Clin Pharmacol 2003;17:125-1.
2. Poole S, Dooley M. Off-label prescribing in oncology. Support Care Cancer 2004;12:302-5.
3. Albaladejo P, Caillet B, Moine P, et al. Off-label prescriptions in an adult surgical intensive care unit. Presse Med 2001;30:1484-8.
4. Ufer M, Kimland E, Bergman U. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden. Pharmacoepidemiol Drug Saf 2004;13:147-52.
5. Choonara I. Unlicensed and off-label drug use in children: implications for safety. Expert Opin Drug Saf 2004;3:81-3.
6. Kucukarslan S, Peters M, Mlynarek M, et al. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 2003;163:2014-8.
7. Radley CD, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Intern Med 2006;166:1021-26.
8. Samama M, Cohen A, Darmon J, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999;341:793-800.
9. Eidelman R, Hebert P, Weisman S, et al. An update on aspirin in the primary prevention of cardiovascular disease. Arch Intern Med 2003;163:2006-10.
10. Kivioja A, Linnosmaa I, Vehvilainen A, et al. Costminimization analysis of treatment of gastroesophageal reflux disease. Implications of varying holding time on conclusions. Eur J Pharm Sci 2004;21:171-8.
11. Bates D, Leape L, Cullen D, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998;280:1311-3.